Atrial Fibrillation Drivers: Redefining the Electrophysiological Substrate

Markus Rottmann; Anna Pfenniger; Shin Yoo; David Johnson; Gail Elizabeth Geist; Suman Mandava; Amy Burrell; Bradley P. Knight; Rod Passman; Rishi Arora

doi:10.1101/2020.12.14.20248171

ABSTRACT

Background We performed high-density mapping of persistent atrial fibrillation (AF) in animals and patients (1) to test that AF is due to ≥1 reentries, and (2) to characterize activation delay and reentries pre/ post pulmonary vein isolation (PVI). We determined electrophysiological characteristics that may predispose to the induction, maintenance, and reduction of AF.

Methods and Results This study includes 48 dogs and nine patients. 43 AF- and five sinus/ paced rhythm dogs (3-14 weeks rapid atrial pacing) were studied at open chest surgery with 117 epicardial electrograms (EGMs) (2.5mm dist.) in 6 bi-atrial regions. Rotational activity automatically detected with a new algorithm tracking the earliest and latest activation in all regions (5±2 per region) were stable over 424±505ms [120– 4940ms]. Reentry stability was highest in the right atrial appendage (RAA) (405±219ms) and the posterior left atrium (PLA) (267±115ms) and anchored between >=3 zones of activation delay (15±5ms, median 13ms) defined as >10ms per 2.5mm. Cycle length (CL) and degree of focal fibrosis were highest in the PLA and left atrial free wall (LAFW) with 94±7ms, 96±5ms, and 49±14%, 47±19%. Fiber crossing density correlated with the stability of rotational activity (R=0.6, P<0.05). Activation delay was 2x higher in AF compared to sinus rhythm/paced rhythm (interval 200-500ms). Activation delay zones > 10ms were at the same locations, but increased 4x during AF vs. SR and were located at fiber crossings, fibrosis/ fat zones. Stability of rotational activity correlated with Organization Index (OI), Fraction Index (FI), Shannon’s Entropy (ShEn), and CL (R>0.5, p< 0.0001). PVI in five hearts increased CL [2-14%] and reduced stability of rotational activity in nearly all regions remote to the pulmonary veins (PVs). Also in the clinical evaluation in nine patients using the HD-catheter (16 electrodes, 3mm dist.) activation delay at the reentrant trajectory was 2x higher at edges with maximal delay (20.5±8.1ms, median 19.6ms) vs (9.3±8.8ms, median 9.2ms) and 1.4 x higher during AF (13.0±18.7ms, median 7.2ms) compared to SR/ CS-pacing (18.0±11.6ms, median 17.7ms).

Conclusion Rotational activities in all bi-atrial regions anchored between small frequency-dependent activation delay zones in AF. PVI led to beneficial remodeling in bi-atrial regions remote to the PVs. These data may identify a new paradigm for persistent AF.

Subject Terms Arrhythmias, Atrial Fibrillation, Cardiac Electrophysiology, High-Density Mapping, Catheter Ablation, Pulmonary Vein Isolation, Fibrosis

What Is New?

Rotational activity trajectories based on high-resolution mapping follow propagation line patterns.
Rotational activities anchor frequently between small frequency-dependent slow conduction zones in all bi-atrial regions.
Slow conduction zones are fiber crossings zones and develop into fibrosis and fat regions over time.
PVI reduces slow conduction zones and AF drivers in regions remote to the PVs in both atria.

What Are the Clinical Implications?

The new method for the robust detection of rotational activity based on the earliest and latest activation may be useful for an improved AF treatment.
Stability of rotational activity may be predicted with the correlated substrate characteristic fiber crossings density, with slow conduction zones, and with established electrogram measures in the different atrial regions.
PVI leads to beneficial remodeling in all regions remote to the PVs in the left atrium and right atrium.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by grants from the American Heart Association and the National Institute of Health, and a grant from Mr. and Mrs. Ronald and JoAnne Willens.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Clinical Retrospective Study: This study and the clinical protocol was approved by the institutional review board (IRB) at Northwestern Memorial Hospital (Northwestern University). Experimental Study: The Animal Care and Use Committee of Northwestern University approved the experimental protocol. The protocol is in line with the Guide for the Care and Use of Laboratory Animal (US National Institutes of Health Publication).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes